NMPA Approval

Rivaroxaban Tablets

Approval Number

国药准字HJ20181085

Registration Date

November 30, 2023

Previous Approval Numbers

H20181085

Drug Information

Generic Name

利伐沙班片

Trade Name

拜瑞妥

Dosage Form

片剂

Strength

15mg

Drug Type

化学药品

Registration Date

November 30, 2023

Expiry Date

November 29, 2028

Company NameBAYER AG

Company Address

51368 Leverkusen, Germany

Company NameBAYER AG

Company Address

Kaiser-Wilhelm-Allee, 51368 Leverkusen, Germany

Empowering clinical research with data-driven insights and AI-powered tools.

利伐沙班片 - NMPA 批准文号 | MedPath